Ari Rosenberg, MD

Paclitaxel

2 trials

phase_1phase_2

Chemoradiation

Standard Dose Radiation

Cetuximab

Cisplatin

Low Dose Radiation

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

+10 more interventions

18 unique interventions3 categories

Analytics

Trial Phases

Phase 13

Phase 22

Phase 31

Trial Status

Recruiting5

Role Distribution

Principal Investigator4

Other Roles1

PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT07768189Phase 3Recruiting

Oropharyngeal Carcinoma (OPC)

StudychairStart date: 2026-09-29

NCT06265727Phase 1/2Recruiting

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Solid Tumor, Adult

PrincipalinvestigatorStart date: 2024-04-01

NCT06005324Phase 1Recruiting

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

HPV-Negative Squamous Cell Carcinoma

PrincipalinvestigatorStart date: 2023-12-18

NCT05526924Phase 1Recruiting

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Head and Neck CancerHead and Neck Cancer Stage IVHead and Neck Cancers - Throat+2 more

PrincipalinvestigatorStart date: 2023-03-07

NCT05420948Phase 2Recruiting

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma+2 more

PrincipalinvestigatorStart date: 2022-10-17

Research Network

Collaboration Network

5 collaborators·6 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Cancer of Head and Neck2 Squamous Cell Carcinoma of Head and Neck2 Head and Neck Cancer Stage IV1 Head and Neck Cancers - Throat1 Head and Neck Carcinoma1 Head and Neck Neoplasms1 Cancer of Head1 HPV-Negative Squamous Cell Carcinoma1

Affiliations

University of Chicago

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ian Hodgson, PhD

Corbus International Ltd

Corbus Pharmaceuticals Inc.CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Shared therapeutic areas:

Solid Tumor, Adult

Worked with same sponsors:

David Pinato, MD

Imperial College London

Corbus Pharmaceuticals Inc.CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Shared therapeutic areas:

Solid Tumor, Adult

Worked with same sponsors:

Pablo Nenclares, MD

Barts & The London NHS Trust

Oropharyngeal Carcinoma (OPC)

Shared therapeutic areas:

Worked with same sponsors:

Corbus Pharmaceuticals Inc.CSPC Megalith Biopharmaceutical Co.,Ltd.

Cesar Peres, MD

Florida Cancer Specialists and Research Institute and Sarah Cannon Research Institute

Oropharyngeal Carcinoma (OPC)

Shared therapeutic areas:

Worked with same sponsors:

Corbus Pharmaceuticals Inc.CSPC Megalith Biopharmaceutical Co.,Ltd.

Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsCancer of Head and Neck

Douglas Adkins, M.D.

Washington University School of Medicine

11 trials

Shared therapeutic areas:

Similarity Score8%

yuankai shi, MD

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

17 trials

Shared therapeutic areas:

Squamous Cell Carcinoma of Head and NeckCancer of Head and Neck

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck

Lillian Siu, MD

Princess Margaret Cancer Centre

12 trials

Shared therapeutic areas:

Solid Tumor, AdultCancer of Head and Neck

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

21 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

18 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and Neck

Ye Guo, MD

Fudan University

13 trials

Shared therapeutic areas: